Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 3
2005 4
2006 4
2007 9
2008 6
2009 5
2010 6
2011 8
2012 9
2013 7
2014 5
2015 5
2016 9
2017 13
2018 10
2019 5
2020 4
2021 4
2022 2
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
Regulation of HOX gene expression in AML.
Khan I, Amin MA, Eklund EA, Gartel AL. Khan I, et al. Among authors: eklund ea. Blood Cancer J. 2024 Mar 7;14(1):42. doi: 10.1038/s41408-024-01004-y. Blood Cancer J. 2024. PMID: 38453907 Free PMC article. Review.
PRL2 Phosphatase Promotes Oncogenic KIT Signaling in Leukemia Cells through Modulating CBL Phosphorylation.
Chen H, Bai Y, Kobayashi M, Xiao S, Barajas S, Cai W, Chen S, Miao J, Nguele Meke F, Yao C, Yang Y, Strube K, Satchivi O, Sun J, Rönnstrand L, Croop JM, Boswell HS, Jia Y, Liu H, Li LS, Altman JK, Eklund EA, Sukhanova M, Ji P, Tong W, Band H, Huang DT, Platanias LC, Zhang ZY, Liu Y. Chen H, et al. Among authors: eklund ea. Mol Cancer Res. 2024 Jan 2;22(1):94-103. doi: 10.1158/1541-7786.MCR-23-0115. Mol Cancer Res. 2024. PMID: 37756563
PRL2 phosphatase enhances oncogenic FLT3 signaling via dephosphorylation of the E3 ubiquitin ligase CBL at tyrosine 371.
Chen H, Bai Y, Kobayashi M, Xiao S, Cai W, Barajas S, Chen S, Miao J, Meke FN, Vemula S, Ropa JP, Croop JM, Boswell HS, Wan J, Jia Y, Liu H, Li LS, Altman JK, Eklund EA, Ji P, Tong W, Band H, Huang DT, Platanias LC, Zhang ZY, Liu Y. Chen H, et al. Among authors: eklund ea. Blood. 2023 Jan 19;141(3):244-259. doi: 10.1182/blood.2022016580. Blood. 2023. PMID: 36206490 Free PMC article.
Comparison of the Transcriptomic Signatures in Pediatric and Adult CML.
Youn M, Smith SM, Lee AG, Chae HD, Spiteri E, Erdmann J, Galperin I, Jones LM, Donato M, Abidi P, Bittencourt H, Lacayo N, Dahl G, Aftandilian C, Davis KL, Matthews JA, Kornblau SM, Huang M, Sumarsono N, Redell MS, Fu CH, Chen IM, Alonzo TA, Eklund E, Gotlib J, Khatri P, Sweet-Cordero EA, Hijiya N, Sakamoto KM. Youn M, et al. Among authors: eklund e. Cancers (Basel). 2021 Dec 14;13(24):6263. doi: 10.3390/cancers13246263. Cancers (Basel). 2021. PMID: 34944883 Free PMC article.
Inhibitory effects of Tomivosertib in acute myeloid leukemia.
Suarez M, Blyth GT, Mina AA, Kosciuczuk EM, Dolniak B, Dinner S, Altman JK, Eklund EA, Saleiro D, Beauchamp EM, Platanias LC. Suarez M, et al. Among authors: eklund ea. Oncotarget. 2021 May 11;12(10):955-966. doi: 10.18632/oncotarget.27952. eCollection 2021 May 11. Oncotarget. 2021. PMID: 34012509 Free PMC article.
106 results